Additional file 2 of The efficacy and safety of selective COX-2 inhibitors for postoperative pain management in patients after total knee/hip arthroplasty: a meta-analysis

Additional file 2: Figure S4. Comparison of VAS score at rest within 3 days after surgery between the selective COX-2 inhibitor group and the control group. (sensitivity analysis). SMD= standardized mean difference. Figure S5. Comparison of VAS score at rest at 24 hours after surgery between the selective COX-2 inhibitor group and the control group. (sensitivity analysis). SMD= standardized mean difference. Figure S6. Comparison of VAS score at rest at 48 hours after surgery between the selective COX-2 inhibitor group and the control group. (sensitivity analysis). SMD= standardized mean difference. Figure S7. Comparison of VAS score at rest at 72 hours after surgery between the selective COX-2 inhibitor group and the control group. (sensitivity analysis). SMD= standardized mean difference. Figure S8. Comparison of VAS score on ambulation within 3 days after surgery between the selective COX-2 inhibitor group and the control group. (sensitivity analysis). SMD= standardized mean difference. Figure S9. Comparison of VAS score on ambulation at 24 hours after surgery between the selective COX-2 inhibitor group and the control group. (sensitivity analysis). SMD= standardized mean difference. Figure S10. Comparison of VAS score on ambulation at 48 hours after surgery between the selective COX-2 inhibitor group and the control group. (sensitivity analysis). SMD= standardized mean difference. Figure S11. Comparison of VAS score on ambulation at 72 hours after surgery between the selective COX-2 inhibitor group and the control group. (sensitivity analysis). SMD= standardized mean difference.